Free Trial
ASX:PBP

Probiotec (PBP) Stock Price, News & Analysis

About Probiotec Stock (ASX:PBP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
26,253 shs
Average Volume
N/A
Market Capitalization
A$242.34 million
P/E Ratio
21.99
Dividend Yield
2.43%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Probiotec and its competitors with MarketBeat's FREE daily newsletter.

PBP Stock News Headlines

2 Incredible Dividend Growers to Buy Hand Over Fist in March
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

PBP Stock Analysis - Frequently Asked Questions

Probiotec Limited (ASX:PBP) released its quarterly earnings data on Tuesday, February, 26th. The company reported $0.02 earnings per share (EPS) for the quarter. Probiotec had a net margin of 5.15% and a trailing twelve-month return on equity of 13.26%.

Company Calendar

Last Earnings
2/26/2019
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:PBP
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
21.99
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$8.69 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$221.22 million
Price / Cash Flow
16.79
Book Value
A$1.07 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$242.34 million
Optionable
Not Optionable
Beta
0.44
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:PBP) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners